SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-018158
Filing Date
2013-03-07
Accepted
2013-03-07 08:01:10
Documents
3
Period of Report
2013-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-6845_18k.htm 8-K 20171
2 EX-99.1 a13-6845_1ex99d1.htm EX-99.1 132117
3 GRAPHIC g68451mmi001.jpg GRAPHIC 2790
  Complete submission text file 0001104659-13-018158.txt   157591
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 13671564
SIC: 2834 Pharmaceutical Preparations